Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E.
暂无分享,去创建一个
K. Campbell | B. Davidson | R. Cohn | R. Williamson | S. Moore | M. Durbeej | Ron F. Hrstka | V. Allamand | R. Hrstka | Roger A. Williamson | Ronald D. Cohn | Madeleine Durbeej | Steven A. Moore | Kevin P. Campbell | V. Allamand | Beverly L. Davidson
[1] T. Negri,et al. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutations , 2000, Journal of medical genetics.
[2] J. Sanes,et al. ε-Sarcoglycan Replaces α-Sarcoglycan in Smooth Muscle to Form a Unique Dystrophin-Glycoprotein Complex* , 1999, The Journal of Biological Chemistry.
[3] K. Campbell,et al. Biochemical Characterization of the Epithelial Dystroglycan Complex* , 1999, The Journal of Biological Chemistry.
[4] H. Hama,et al. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. , 1999, Human molecular genetics.
[5] K. Campbell,et al. Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy , 1999, Cell.
[6] J. Sanes,et al. Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex , 1999, The Journal of cell biology.
[7] E. Hoffman,et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations , 1999, Muscle & nerve.
[8] C. Leveille,et al. Molecular Pathogenesis of Muscle Degeneration in the δ-Sarcoglycan-Deficient Hamster , 1998 .
[9] K. Campbell,et al. The sarcoglycan complex in limb-girdle muscular dystrophy. , 1998, Current opinion in neurology.
[10] K. Campbell,et al. Dystroglycan in development and disease. , 1998, Current opinion in cell biology.
[11] John A. Faulkner,et al. Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice , 1998, The Journal of cell biology.
[12] R. Wollmann,et al. γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin , 1998, The Journal of cell biology.
[13] K. Campbell,et al. Caveolin‐3 is not an integral component of the dystrophin glycoprotein complex , 1998, FEBS letters.
[14] K. Campbell,et al. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer. , 1998, Molecular cell.
[15] C. Bönnemann,et al. LGMD 2E in Tunisia is caused by a homozygous missense mutation in β-sarcoglycan exon 3 , 1998, Neuromuscular Disorders.
[16] J. Towbin,et al. The role of cytoskeletal proteins in cardiomyopathies. , 1998, Current opinion in cell biology.
[17] F. Quétier,et al. β-Sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate , 1998, Neuromuscular Disorders.
[18] L. Kunkel,et al. Human ϵ‐sarcoglycan is highly related to α‐sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene 1 , 1998, FEBS letters.
[19] J. Sanes,et al. ε-Sarcoglycan, a Broadly Expressed Homologue of the Gene Mutated in Limb-Girdle Muscular Dystrophy 2D* , 1997, The Journal of Biological Chemistry.
[20] Y. Murakami,et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] K. Campbell,et al. Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption , 1997, The Journal of cell biology.
[22] J. Sanes,et al. Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.
[23] E. Engvall,et al. Mouse adhalin: primary structure and expression during late stages of muscle differentiation in vitro. , 1997, Biochemical and biophysical research communications.
[24] K. Campbell,et al. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. , 1997, Human molecular genetics.
[25] K. Campbell,et al. Muscular dystrophies and the dystrophin-glycoprotein complex. , 1997, Current opinion in neurology.
[26] L. Kunkel,et al. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). , 1996, Human molecular genetics.
[27] J. Beckmann,et al. β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12 , 1995, Nature Genetics.
[28] L. Kunkel,et al. β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex , 1995, Nature Genetics.
[29] A. Nishikawa,et al. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. , 1995, Journal of biochemistry.
[30] S. Noguchi,et al. Dystrophin-associated proteins in muscular dystrophy. , 1995, Human molecular genetics.
[31] B. Davidson,et al. Expression of Escherichia coli β-Galactosidase and Rat HPRT in the CNS of Macaca mulatta Following Adenoviral Mediated Gene Transfer , 1994, Experimental Neurology.
[32] O. Ibraghimov-Beskrovnaya,et al. Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin). , 1993, The Journal of biological chemistry.
[33] J. Ervasti,et al. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin , 1993, The Journal of cell biology.
[34] H. Sweeney,et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Small,et al. Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle , 1993, The Journal of cell biology.
[36] G. Lyons,et al. Localization of dystrophin gene transcripts during mouse embryogenesis , 1992, The Journal of cell biology.
[37] K. Campbell,et al. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice , 1991, The Journal of cell biology.
[38] J. Ervasti,et al. Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.
[39] J. Ervasti,et al. Purification of dystrophin from skeletal muscle. , 1991, The Journal of biological chemistry.
[40] K. Jaffe,et al. Symptoms of upper gastrointestinal dysfunction in Duchenne muscular dystrophy: case-control study. , 1990, Archives of physical medicine and rehabilitation.
[41] J. O. Olson,et al. Gastric hypomotility in Duchenne's muscular dystrophy. , 1988, The New England journal of medicine.
[42] Eric P. Hoffman,et al. Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.
[43] E. Sonnenblick,et al. Microvascular Spasm in the Cardiomyopathic Syrian Hamster: A Preventable Cause of Focal Myocardial Necrosis , 1982, Circulation.
[44] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.
[45] S. Froehner,et al. Syntrophins: modular adapter proteins at the neuromuscular junction and the sarcolemma. , 1997, Society of General Physiologists series.